Egyptian Heart Journal最新文献

{"title":"Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes","authors":"Helmy Hassan Elghawaby,&nbsp;Mohamed Ashraf Shawky,&nbsp;Ahmed Hossam Mowafi,&nbsp;Akram Mohamed Abd-elbary,&nbsp;Farouk Mostafa Faris","doi":"10.1016/j.ehj.2017.05.003","DOIUrl":"10.1016/j.ehj.2017.05.003","url":null,"abstract":"<div><h3>Background</h3><p>Disruption of vulnerable plaques is the most common cause of acute coronary syndromes. Intravascular ultrasound facilitates cross-sectional imaging of coronary arteries. We aimed at using IVUS to investigate the morphology and tissue characteristics of atherosclerotic plaques of non-culprit intermediate coronary lesions in non-ST elevation ACS setting.</p></div><div><h3>Methods</h3><p>IVUS assessment of sixty-one intermediate coronary lesions in twenty-eight patients with the diagnosis of Non ST elevation acute coronary syndromes. Ultrasound signals were obtained by an IVUS system using a 40-MHz catheter.</p></div><div><h3>Results</h3><p>Mean age was 53.2<!--> <!-->±<!--> <!-->9.1<!--> <!-->years. Males<!--> <!-->=<!--> <!-->20 (71.4%). Smoking in 17 (60.7%), hypertension in 16 (57.1%), Dyslipidemia in 12 (42.9%) and DM in 8 (28.6%). Culprit vessels represent 42% of affected vessels. Sixty-one intermediate lesions were detected. Twenty-nine lesions in culprit vessels and thirty-two lesions in non-culprit vessels with higher lipidic content in lesions of culprit vessels (<em>P</em> <!-->&lt;<!--> <!-->0.001) while a higher calcific content in lesions of non-culprit vessels (<em>P</em> <!-->&lt;<!--> <!-->0.001). Higher calcific content of proximal more than distal lesions (<em>P</em> <!-->=<!--> <!-->0.048). Negative remodeling in 55.7% of lesions.</p></div><div><h3>Conclusions</h3><p>A higher lipidic content in lesions of culprit vessels, while the lesions of non-culprit vessels were more calcific. Higher calcific content of proximal more than distal lesions was defined as well.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 9-14"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.05.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach","authors":"El-Zahraa M. Sultan ,&nbsp;Hoda M. Rabea ,&nbsp;Khaled R. abdelmeguid ,&nbsp;Hesham B. Mahmoud","doi":"10.1016/j.ehj.2017.04.001","DOIUrl":"10.1016/j.ehj.2017.04.001","url":null,"abstract":"<div><p>The purpose of the study was to investigate the safety and efficacy of transradial artery approach (TRA) in STEMI patients who reperfused early (≤3<!--> <!-->h from symptoms onset) or late (&gt;3<!--> <!-->h from symptoms onset) by either PPCI or pharmaco-invasive strategy (PI), thrombolysis followed by CA. Therefore, a total 143 STEMI patients (who were presented within 12<!--> <!-->h from symptoms onset or 12–24<!--> <!-->h with an evidence of ongoing ischemia or suffered from an acute STEMI were randomized for either PI or PPCI. Eighty-two patients were assigned to PI arm while the rest assigned were to PPCI arm. Patients who were taken to a non-PCI capable hospital received streptokinase and were then transferred to our Hospital for CA. TRA was used in the catheterization laboratory for all patients. Each arm was divided according to reperfusion time into early and late subgroups. A primary endpoint was death, shock, congestive heart failure, or reinfarction up to 30<!--> <!-->days. There was a non-significant difference regarding LVEF in both arms. Myocardium wall preservation was significant in the early PI arm (<em>P</em> <!-->=<!--> <!-->0.023). TIMI flow had no discrepancy between both arms (<em>P</em> <!-->=<!--> <!-->0.569). Mean procedural and fluoroscopic time were 35.1<!--> <!-->±<!--> <!-->6.1 and 6.3<!--> <!-->±<!--> <!-->0.9<!--> <!-->min. There were no reported entry site complications. There was no difference in primary endpoint complications (<em>P</em> <!-->=<!--> <!-->0.326) considering the different times of patients’ reperfusion (early; <em>P</em> <!-->=<!--> <!-->0.696<!--> <!-->vs. late; <em>P</em> <!-->=<!--> <!-->0.424). In conclusion, it is safe and effective to use TRA in STEMI patients who reperfused by either early or late PPCI or PI. We recommend PI for STEMI patients with delay presentation if PPCI is not available.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 1-7"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Increased arterial stiffness in rheumatoid arthritis and Its relation to disease activity: A cross sectional study","authors":"Ghada Youssef ,&nbsp;Nashwa Taher Allam ,&nbsp;Wafaa Gaber ,&nbsp;Angie Afifi ,&nbsp;Dina Hesham","doi":"10.1016/j.ehj.2017.11.002","DOIUrl":"10.1016/j.ehj.2017.11.002","url":null,"abstract":"<div><h3>Background</h3><p>Rheumatoid arthritis (RA) is associated with elevated plasma level of inflammatory markers. Chronic inflammation is known to predispose to endothelial dysfunction and increased arterial stiffness, which is an important marker of subclinical atherosclerosis and increased cardiovascular risk.</p></div><div><h3>Objective</h3><p>The aim is to test for the relationship between disease activity and arterial stiffness in RA patients.</p></div><div><h3>Methods</h3><p>The study included 90 RA patients, at different grades of disease activity and 45 healthy subjects, as a control group. Patients were subjected to full history taking and clinical examination, laboratory investigations including serum lipid profile and high sensitivity CRP (hs-CRP) measurements and plain x-rays of hands and feet. Modified Larsen method was used as radiographic scoring method. Disease activity score (DAS 28) was used for assessment of disease activity. Transthoracic echocardiography was performed to detect aortic stiffness parameters. Duplex ultrasound imaging of both common carotid arteries was performed to measure carotid stiffness parameters.</p></div><div><h3>Results</h3><p>The mean age of RA patients was 39.86 ± 9.39 years and most of them (83.3%) were females. RA patients had higher carotid stiffness index compared to control group patients (8.57 ± 4.83 vs 4.08 ± 1.13, p &lt; .001). Very poor correlation was found between DAS-28 and aortic (r = 0.1, p = .28) as well as carotid (r = 0.05, p = .7) stiffness indices. No statistically significant correlation was found between hs-CRP and aortic stiffness index (r = 0.64, p = .55). Disease duration was significantly correlated to intima-media thickness (p &lt; .01) as well as with other carotid stiffness parameters. Age also show a statistically significant positive correlation with carotid stiffness parameters.</p></div><div><h3>Conclusion</h3><p>RA is associated with increased arterial stiffness, a well-recognized marker of cardiovascular risk. This is attributed to the inflammatory nature of the disease. It seems that the most important factors determining stiffness are patients' age and duration of illness.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 35-40"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.11.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bleeding and asymptomatic overdose in patients under Vitamin K antagonist therapy: Frequency and risk factors","authors":"F. Ben Mbarka,&nbsp;K. Ben Jeddou,&nbsp;E. Allouche,&nbsp;I. Boukhris,&nbsp;N. Khalfallah,&nbsp;H. Baccar,&nbsp;Z. Ouahchi","doi":"10.1016/j.ehj.2018.01.001","DOIUrl":"10.1016/j.ehj.2018.01.001","url":null,"abstract":"<div><h3>Background</h3><p>Vitamin K antagonists are widely used in the treatment and prevention of thromboembolic disease. However, these drugs can cause serious side effects, especially bleeding. This study aims to evaluate frequency and risk factors of both bleeding and asymptomatic overdose in North African patients undergoing Vitamin K antagonist therapy.</p></div><div><h3>Methods</h3><p>We performed a cross-sectional study in patients undergoing Vitamin K antagonist therapy. A statistical analysis has been conducted to identify overdose and bleeding risk factors by using chi-square test (p &lt; .05).</p></div><div><h3>Results</h3><p>One hundred and eleven patients were included. We recorded 14 cases of bleeding and 26 cases of asymptomatic overdose. Advanced age, poor adherence, concomitant use of paracetamol and history of previous bleeding are significant risk factors of over-anticoagulation. An INR value over 6 at admission, a high therapeutic target range for INR, concomitant use of acetylsalicylic acid, lack of information on overdose signs and measures to be taken in case of bleeding were identified as risk factors for bleeding.</p></div><div><h3>Conclusion</h3><p>Most of the risk factors identified in our study seem to be related to patients lack of information and education. These results highlight the importance of creating a therapeutic patient education program.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 45-49"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2018.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stent boost enhancement compared to intravascular ultrasound in the evaluation of stent expansion in elective percutaneous coronary interventions","authors":"Mohamed Laimoud,&nbsp;Yasser Nassar,&nbsp;Walid Omar,&nbsp;Akram Abdelbarry,&nbsp;Helmy Elghawaby","doi":"10.1016/j.ehj.2017.09.001","DOIUrl":"10.1016/j.ehj.2017.09.001","url":null,"abstract":"<div><h3>Background</h3><p>Stent underexpansion is a major risk factor for in-stent restenosis and acute in-stent thrombosis¹Intravascular ultrasound (IVUS) is one of the standards for detection of stent underexpansion (de Feyter et al. 1999; Mintz et al., 2001). StentBoost (SB) enhancement allows an improved angiographic visualization of the stent (Koolen et al., 2005).</p></div><div><h3>Aim of work</h3><p>Comparison of stent expansion by IVUS and SB enhancement and detection of value of SB to guide dilatation post stent deployment.</p></div><div><h3>Methodology</h3><p>IVUS, SB enhancement and QCA were done in 30 patients admitted for elective stenting procedures .We compared measurements of mean ±standard deviations of (Max SD, Min SD, Mean SD, stent symmetry index) using IVUS, SB and QCA after stent deployment and after postdilatation whenever necessary to optimize stent deployment. <em>The Stent symmetry index was calculated</em> [(maximum stent diameter minus minimum stent diameter) divided by maximum stent diameter].</p></div><div><h3>Results</h3><p>The Max SD was (3.45 ± 0.62 vs 3.55 ± 0.56 vs 2.97 ± 0.59) by IVUS vs SB vs QCA respectively. Max SD was significantly higher by IVUS vs QCA (p .009) and between SB vs QCA (p .001) while there was nonsignificant difference between IVUS vs SB (p .53). The Min SD was (2.77 ± 0.53 vs 2.58 ± 0.56 vs 1.88 ± 0.60) by IVUS vs SB vs QCA respectively. Min SD was significantly higher by IVUS vs QCA (p .001) and between SB vs QCA (p .001) while there was nonsignificant difference between IVUS vs SB (p .07). The stent symmetry index was (0.24 ±0.09 vs 0.34 ± 0.09 vs 0.14 ±0.27) by IVUS vs SB vs QCA respectively. It was significantly higher by IVUS vs QCA (p .001) and between SB vs QCA (p .001) while there was nonsignificant difference between IVUS vs SB (p .32). SB was positively correlated with IVUS measurements of Max SD (p &lt;<!--> <!-->.0001 &amp; r 0.74) and Min SD (p &lt;<!--> <!-->.0001 &amp; r 0.68). QCA was positively correlated with IVUS measurements of Max SD correlation (p &lt;<!--> <!-->.0001 &amp; r 0.69) and Min SD (p &lt;<!--> <!-->.0001 &amp; r 0.63). QCA was positively correlated with SB measurements of Max SD (p &lt;<!--> <!-->.0001 &amp; r 0.61) and Min SD (p .003 &amp; r 0.49).</p></div><div><h3>Conclusions</h3><p>StentBoost enhancement has superior correlations for stent expansion measured by IVUS when compared with QCA. SB enhancement improved stent visualization and identification of stent underexpansion to guide stent postdilatation.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 21-26"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical profile, management and outcome of pulmonary embolism in Shahid Gangalal National Heart Centre, Kathmandu, Nepal","authors":"Chandra Mani Adhikari ,&nbsp;Bishal K.C. ,&nbsp;Sobita Khadka","doi":"10.1016/j.ehj.2017.06.001","DOIUrl":"10.1016/j.ehj.2017.06.001","url":null,"abstract":"<div><h3>Background and aims</h3><p>Pulmonary embolism (PE) is associated with a significant mortality and morbidity. We aim to study clinical profile, management and outcome of PE at Shahid Gangalal National heart Centre, Kathmandu, Nepal.</p></div><div><h3>Methods</h3><p>It was a retrprospective, single centre study, conducted from January 2015 to December 2016. Haemodynamics was used for risk Simplified, PESI score, predisposing factors, symptoms, clinical features at the time of admission, ECG features, echocardiogram, treatment received and the outcome were reviewed.</p></div><div><h3>Results</h3><p>During the study period 23 cases of PE were admitted. Nine were males and 14 were females. Eleven patients were diagnosed as provoked PE. High risk PE was diagnosed in four patients, Non-high risk in 19 patients. The most common clinical presentation was shortness of breath. The most common finding in ECG is sinus tachycardia followed by ST-T changes in V1-V3. Eight patient had SPO2 less than 90%. Most of the patients had a normal chest radiograph. Echocardiography revealed dilated RA and RV in 20 patients.</p><p>All high risk PE patients were thrombolyzed with streptokinase. All patients who were diagnosed as Non-high risk PE were treated with LMWH. All the patients were treated with oral anticoagulants. Mean hospital stay was 9.7<!--> <!-->±<!--> <!-->4.9<!--> <!-->days. Two patients died during hospital stay. S-PESI score was 1.4<!--> <!-->±<!--> <!-->0.9 respectively. Mean warfarin dose at the time of discharge was 5.9<!--> <!-->±<!--> <!-->1.6<!--> <!-->mg.</p></div><div><h3>Conclusion</h3><p>PE is an under diagnosed clinical problem world over. Suspicion is the most important part to come to the diagnosis of PE.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 41-43"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiovascular risk of circulating endotoxin level in prevalent hemodialysis patients","authors":"Mohamed Ibrahim ,&nbsp;Maha Behairy ,&nbsp;Marwa El-Ashry ,&nbsp;Ahmad E. Mostafa","doi":"10.1016/j.ehj.2017.06.003","DOIUrl":"10.1016/j.ehj.2017.06.003","url":null,"abstract":"<div><h3>Background</h3><p>Cardiovascular diseases (CVDs) are a major cause of morbidity and mortality in patients with end stage renal disease (ESRD). Circulating endotoxins may have toxic effect on myocardial functions and are speculated as pathogens of accelerated atherosclerosis and hemodialysis (HD) patients.</p></div><div><h3>Objective</h3><p>We aimed to assess the possible relation between circulating endotoxin levels and left ventricular functions parameters, common carotid artery intimal media thickness (CIMT) in prevalent HD patients.</p></div><div><h3>Patients and Methods</h3><p>Forty stable prevalent HD patients with mean age (47.97<!--> <!-->±<!--> <!-->14.42) year using regular conventional hemodialysis sessions in Ain shams university hemodialysis unit, Cairo, Egypt were randomly selected. Diabetics, congestive heart failure and those with history of myocardial infarction or coronary artery disease were excluded from the study. All patients were studied by CBC and routine chemistry, as well as hs CRP, Intact PTH, lipid profile and endotoxin level by ELISA before and after the HD session, Delta change of endotoxin (pre dialysis endotoxin-post dialysis endotoxin) was calculated, resting Doppler echocardiographic and carotid duplex.</p></div><div><h3>Results</h3><p>Mean of Pre-HD session serum endotoxin level was (0.356<!--> <!-->±<!--> <!-->0.090) EU/mL and the mean of post -HD endotoxin levels was (0.367<!--> <!-->±<!--> <!-->0.110) EU/mL. Significant positive correlation between post dialysis endotoxin, MV E/A ratio and grades of left ventricular diastolic dysfunction (P<!--> <!-->&lt;<!--> <!-->0.05) and significant correlation between delta change in endotoxin and EF% (r<!--> <!-->=<!--> <!-->−0.36,P<!--> <!-->=<!--> <!-->0.02). By stepwise linear regression analysis for determinants of MVE/A post –HD endotoxin level independently associated with MV E/A ratio (ß<!--> <!-->=<!--> <!-->0.350, P<!--> <!-->=<!--> <!-->0.027). We did not detect any significant correlation between CCA atherosclerosis and neither pre nor post- HD endotoxin level nor with delta change of pre and post HD endotoxin levels.</p></div><div><h3>Conclusion</h3><p>Acute increase in post dialytic circulating endotoxin level in prevalent HD patients may be associated with both left ventricular systolic and diastolic dysfunction and that attempts to reduce endotoxin level may have a positive impact on cardiovascular complications in HD Patients.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"70 1","pages":"Pages 27-33"},"PeriodicalIF":1.1,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35981859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tricuspid valve repair with Dacron band versus DeVega or segmental annuloplasty. Hospital outcome and short term results","authors":"Ahmed Abdelgawad ,&nbsp;Mona Ramadan ,&nbsp;Heba Arafat ,&nbsp;Ahmed Abdel Aziz","doi":"10.1016/j.ehj.2017.05.004","DOIUrl":"10.1016/j.ehj.2017.05.004","url":null,"abstract":"<div><h3>Background</h3><p>The purpose of this study was to compare the hospital outcome and short term results of tricuspid valve (TV) repair with three repair techniques for functional tricuspid regurgitation (TR), namely, flexible Dacron band, DeVega and segmental annuloplasty.</p></div><div><h3>Methods</h3><p>A total of 60 patients underwent TV repair at National Heart Institute from January 2013 to November 2014, of which 20 had DeVega procedure (DV), 20 had a segmental annuloplasty (SA) procedure and 20 had a Dacron band (DB) procedure. Concomitant procedures done for rheumatic left sided valve pathology consisted of mitral valve replacement in 70% of patients, and double valve replacement in 30% of patients. Clinical and echocardiographic follow-up data were obtained. Follow-up was 100% complete and was concluded after one year.</p></div><div><h3>Results</h3><p>All demographic criteria and preoperative characteristics of the three studied groups were comparable except for preoperative right ventricular (RVEDD) size that was significantly bigger in Dacron band group as compared to the other two groups (3.18<!--> <!-->±<!--> <!-->0.43<!--> <!-->cm compared to 3.00<!--> <!-->±<!--> <!-->0.33<!--> <!-->cm (DV) and to 2.88<!--> <!-->±<!--> <!-->0.35<!--> <!-->cm (SA), p value of (0.045)). Similarly, all operative and postoperative criteria were comparable among the study groups. Noticeably, (RVEDD) size remodeled better postoperatively in (DB) group as compared to the other two groups, (2.54<!--> <!-->±<!--> <!-->0.26<!--> <!-->cm compared to 2.83<!--> <!-->±<!--> <!-->0.311<!--> <!-->cm (DV) and to 2.72<!--> <!-->±<!--> <!-->0.29<!--> <!-->cm (SA), mean difference values were group (0.64<!--> <!-->±<!--> <!-->0.47<!--> <!-->cm) for (DB) compared to (0.18<!--> <!-->±<!--> <!-->0.29<!--> <!-->cm) for (DV) or to (0.16<!--> <!-->±<!--> <!-->0.45<!--> <!-->cm) for (SA) with p value of 0.000. The majority of patients in each group did not have tricuspid regurgitation (TR) or mild degree (+1) of (TR) on discharge. After one year of follow-up, most of the patient had either no regurgitation or grade (+1 TR). Two patients (10%) in DV group and one patient (5%) in SA group had (+3 TR). There was no statistical significance in the incidence of hospital mortality, only one patient died in DB and one in DV group (5%) and no death happened after hospital mortality for the three groups after one year.</p></div><div><h3>Conclusions</h3><p>The three techniques are options to repair the tricuspid valve, however, placement of Dacron band in patients undergoing tricuspid valve repair is associated with better RV remodelling, and hence, a probable better right ventricular performance and better outcome of repair is expected. A higher number of patients are needed with longer follow up period to appreciate the effect on survival and rate of freedom from tricuspid regurgitation and re-intervention.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"69 4","pages":"Pages 241-246"},"PeriodicalIF":1.1,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35983465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcome of transcatheter aortic valve implantation in high risk patients with severe aortic stenosis","authors":"Hamdy Soliman ,&nbsp;Khlid Alrabaat ,&nbsp;Tarek Aboalaazm ,&nbsp;Shaimaa Mostafa ,&nbsp;Asaad Samy","doi":"10.1016/j.ehj.2017.07.003","DOIUrl":"10.1016/j.ehj.2017.07.003","url":null,"abstract":"<div><h3>Aim</h3><p>To assess outcome of TAVI in high risk patients with severe symptomatic aortic stenosis.</p></div><div><h3>Patients and methods</h3><p>40 patients with symptomatic severe aortic stenosis and high risk underwent TAVI with implantation of either Sapien XT valve or Core Valve and followed for 6<!--> <!-->months. Device success, cardiovascular mortality, myocardial infarction, stroke, life-threatening bleeding and vascular complications were defined according to Valve Academic Research Consortium definitions.</p></div><div><h3>Results</h3><p>The study included 40 patients, their mean age was 73.98<!--> <!-->±<!--> <!-->8.40, procedural success was 97.5%. One patient need valve in valve due to moderately severe paravalvular leak. Total mortality was 7.5%, cardiovascular death occurred in 2.5% and non cardiovascular death occurred in 5%. Myocardial infarction occurred in one patient (2.5%), stroke occurred in 2 patients (5%), minor bleeding occurred in 6 patients (15%), major bleeding occurred in 3 patients (7.5%), minor vascular complications occurred in 4 patients (10%) while major vascular complications occurred in 3 patients (7.5%). Permanent pacemaker was inserted for 5 patients (12.5%), new onset AF occurred in 4 patients (10%). Re hospitalization was needed for 2 patients (5%) due to heart failure. After TAVI there were significant improvement in NYHA functional class (p<!--> <!-->&lt;<!--> <!-->0.001), mean LV ejection fraction and LV mass index (p<!--> <!-->&lt;<!--> <!-->0.001), mean aortic valve area, mean and peak pressure gradient (p<!--> <!-->&lt;<!--> <!-->0.001), severity of aortic and mitral regurgitation (p<!--> <!-->&lt;<!--> <!-->0.001). When comparing types of valves used, both were nearly comparable.</p></div><div><h3>Conclusion</h3><p>TAVI is a safe and effective procedure in selected high-risk patients with severe symptomatic aortic stenosis without significant difference between used valves.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"69 4","pages":"Pages 261-271"},"PeriodicalIF":1.1,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35983468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Myocardial bridging as one of the causes of atypical chest pain in young women","authors":"M. Jukić ,&nbsp;L. Pavić ,&nbsp;I. Bitunjac ,&nbsp;T. Jukić ,&nbsp;M. Milošević ,&nbsp;D. Lovrić ,&nbsp;M. Lovrić Benčić","doi":"10.1016/j.ehj.2017.03.005","DOIUrl":"10.1016/j.ehj.2017.03.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Myocardial bridging is congenital anomaly which usually has benign prognosis but there are also reports suggesting that it can be associated with ischemic clinical syndromes presenting with chest pain. Coronary computed tomography angiography is a well-established method for detecting myocardial bridging. However, clinical significance of this anomaly still remains unclear.</p></div><div><h3>Methods</h3><p>We studied 977 patients who presented with recurrent typical or atypical chest pain in outpatient clinic. All patients have undergone detailed clinical examination, ECG stress testing and coronary computed tomography angiography.</p></div><div><h3>Results</h3><p>Highest positive prediction for having myocardial bridging was for patients presenting with atypical chest pain with negative ECG stress test and who were younger women.</p></div><div><h3>Conclusion</h3><p>Coronary computed tomography angiography may be preferable method for evaluation of chest pain in younger women presenting with atypical chest pain.</p></div>","PeriodicalId":44962,"journal":{"name":"Egyptian Heart Journal","volume":"69 4","pages":"Pages 235-239"},"PeriodicalIF":1.1,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehj.2017.03.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35983464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}